Management of well-differentiated thyroid cancer in 2010: Perspectives of a head and neck surgical oncologist

Endocrine Practice

Volumn 16, Issue 5, 2010, Pages 903-912

  Urken, Mark L ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORPHOLOGY; CANCER STAGING; HEAD AND NECK SURGERY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENOPATHY; MEDICAL DECISION MAKING; NOMENCLATURE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY TUMOR; PROGNOSIS; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; THYROID CANCER; THYROIDECTOMY; TUMOR DIFFERENTIATION;

CARCINOMA, PAPILLARY, FOLLICULAR; CELL DIFFERENTIATION; ENDOCRINOLOGY; GENERAL SURGERY; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MEDICAL ONCOLOGY; MODELS, BIOLOGICAL; THYROID NEOPLASMS;

EID: 78149298221     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP10133.RA     Document Type: Review

References (41)

1. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
2. Cooper DS, Doherty GM, Haugen BR, et al; American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109-142.
3. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce. European Consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787-803.
4. Urken, ML. Prognosis and management of invasive welldifferentiated thyroid cancer. Otolaryngol Clin North Am. 2010;43:301-328, viii.
5. Bilimoria KY, Bentem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007:246:375-384.
6. Ross DS, Litofsky D, Ain K, et al. Recurrence after treatment of micropapillary thyroid cancer. Thyroid. 2009;19:1043-1048.
7. American Thyroid Association Surgery Working Group, American Association of Endocrine Surgeons, American Academy of Otolaryngology-Head and Neck Surgery, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19:1153-1158.
8. Edge S, Byrd D, Compton C, et al, eds. Thyroid in AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2010.
9. Noguchi M, Yamada H, Ohta H, et al. Regional lymph node metastases in well-differentiated thyroid carcinoma. Int Surg. 1987;72:100-103.
10. Pereira JA, Jimeno J, Miquel J, et al. Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery. 2005;138:1095-1100.
11. Machens A, Holzhausen H, Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg. 2004;139:43-45.
12. Wada N, Duh QY, Sugino K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003;237:399-407.
13. Machens A, Holzhausen HJ, Dralle H. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer. 2005;103:2269-2273.
14. Rodolico V, Cabibi D, Pizzolanti G, et al. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid
15. Henderson YC, Shellenberger TD, Williams MD. High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma. Clin Cancer Res. 2009;15:485-491.
16. Bonnet S, Harti D, Leboulleux S, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: Implications for radioiodine treatment. J Clin Endocrinol Metab. 2009;94:1162-1167.
17. Grant CS, Stulak JM, Thompson GB, Richards ML, Reading CC, Hay ID. Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006. World J Surg. 2010;34:1239-1246.
18. Choi JS, Kim J, Kwak JY, Kim MJ, Chang HS, Kim EK. Preoperative staging of papillary thyroid carcinoma: Comparison of ultrasound imaging and CT. AJR Am J Roentgenol. 2009;193:871-878.
19. White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg. 2007;31:895-904.
20. Sywak M, Comford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery. 2006;140:1000-1005.
21. Koo BS, Choi EC, Yoon YH, Kim DH, Kim EH, Lim YC. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg. 2009;249:840-844.
22. Raijmakers PG, Paul MA, Lips P. Sentinel node detection in patients with thyroid carcinoma: A meta-analysis. World J Surg. 2008;32:1961-1967.
23. Lee SK, Choi JH, Lim HI, et al. Sentinel lymph node biopsy in papillary thyroid cancer: Comparison study of blue dye method and combined radioisotope and blue dye method in papillary thyroid cancer. Eur J Surg Oncol. 2009;35:974-979
24. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid. 2003;13:381-387.
25. Shindo M, Wu JC, Park EE, Tanzella F. The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg. 2006;132:650-654.
26. Palazzo FF, Gosnell J, Savio R, et al. Lymphadenectomy for papillary thyroid cancer: Changes in practice over four decades. Eur J Surg Oncol. 2006;32:340-344.
27. Perrino M, Vannucchi G, Vicentini L, et al. Outcome predictors and impact of central node dissection and radiometabolic treatments in papillary thyroid cancers < or = 2 cm. Endocr Relat Cancer. 2009;16:201-210.
28. Bhattacharyya N, Fried MP. Assessment of the morbidity and complications of total thyroidectomy. Arch Otolaryngol Head Neck Surg. 2002;128:389-392.
29. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: Addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery. 2004;135:139-148.
30. Machens A, Hauptmann S, Dralle H. Lymph node dissection in the lateral neck for completion in central node positive papillary thyroid cancer. Surgery. 2009;145:176-181.
31. Simon D, Goretzki PE, Witte J, Röher H. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg. 1996;20:860-866.
32. Marchesi M, Biffoni M, Biancari F, Berni A, Campana FP. Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma. Eur J Surg Suppl. 2003;588:46-50.
33. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947-953.
34. Noguchi S, Murakami N, Yamashita H, Toda M, Kawamoto H. Papillary thyroid carcinoma: Modified radical neck dissection improves prognosis. Arch Surg. 1998;133:276-280.
35. Ito Y, Higashiyama T, Takamura Y, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: Validity of prophylactic modified radical neck dissection. World J Surg. 2007;31:2085-2091.
36. Mirallié E, Sagan C, Hamy A, et al. Predictive factors for node involvement in papillary thyroid carcinoma. Univariate and multivariate analyses. Eur J Cancer. 1999;35:420-423.
37. Ghossein R, Asa S. Barnes L, et al. Protocol for the examination of specimens from patients with carcinomas of the thyroid gland. College of American Pathology. October 2009. Available at: http://lester-thompson.com/ articles/Others/CAP-Thyroid-2009-Protocol.pdf. Accessed July 16, 2010.
38. Goretzki PE, Simon D, Frilling A, et al. Surgical reintervention for differentiated thyroid cancer. Brit J Surg. 1993;80:1009-1012.
39. Yamashita H, Noguchi S, Murakami N, Kawamoto H, Watanabe S. Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer. 1997;80:2268-2272.
40. Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab. 2005;90:5723-5729.
41. Ito Y, Hirokawa M, Jikuzono T, et al. Extranodal tumor extension to adjacent organs predicts worse cause-specifc survival in patients with papillary thyroid carcinoma. World J Surg. 2007;31:1194-1201.